26 januari 2023

O4 Report - Important steps forward in a challenging environment. Read the PR here: https://t.co/waSrsib4HC To just… https://t.co/coLzf86ELS

25 januari 2023

Our Q4 Report will be published tomorrow at 8 am CET. In the afternoon at 2 pm investors, analysts & media are much… https://t.co/S1J4xbAa4o

20 januari 2023

New BLOG post out: “We lost our youngest son, Charlie, to a single counterfeit Percocet.” Discover what happened wh… https://t.co/dcwheNzMUx

Europa

USA

USA

Lena Wange

IR & Corporate Communications Director

Växel: +46 (0)18 780 88 00

Direktnummer: +46 73 064 16 36

Email: ir@orexo.com

Plats: Uppsala, Sverige

Robert A. DeLuca

President Orexo US Inc.

Växel: +1 (0)855 982 7658

Email: us.media@orexo.com

Plats: New Jersey, US

Dennis Urbaniak

EVP Digital Therapeutics

Växel: +1 (0)855 982 7658

Direktnummer: +1 973 294 3183

Email: us.media@orexo.com

Plats: New Jersey, USA